Effect of dose fractionation on the enhancement by radiation or cyclophosphamide of artificial pulmonary metastases
- PMID: 678423
- PMCID: PMC2009663
- DOI: 10.1038/bjc.1978.148
Effect of dose fractionation on the enhancement by radiation or cyclophosphamide of artificial pulmonary metastases
Abstract
Thoracic irradiation or cyclophosphamide (CP) treatment of mice before an i.v. injection of tumour cells enhances the number of lung colonies produced by a factor of up to 100+. The effect of fractionation of the X-ray or CP dose on this phenomenon was investigated in several ways.The dose-response curve for the number of lung colonies as a function of the dose of thoracic irradiation was linear, and the degree of enhancement was independent of the number of tumour cells injected. Splitting a dose of 1,000 rad into 2 equal fractions separated by times varying from 1 to 24 h gave the same enhancement as that produced by a single dose of 1000 rad. Similarly, fractionation of 1000 rad into 5 × 200 rad, or 2000 rad into 5 × 400 rad (each interval between fractions being 3 h) had no effect on the radiation enhancement of colony formation.A single dose of 200 mg/kg of CP was compared with 3 doses of 66·7 mg/kg (each dose separated by 12 h) and with a continuous infusion of 200 mg/kg given over 24 h. In this case, fractionation and infusion produced a small reduction in the CP-induced increase, but the factor of colony enhancement compared to control mice remained >100.These data emphasize the potential hazard of prophylactic treatment of pulmonary metastases by X-rays or CP in clinical situations in which control of the primary tumour is not achieved.
Similar articles
-
Residual damage in mouse lungs at long intervals after cyclophosphamide treatment.Cancer Res. 1990 Apr 1;50(7):2139-45. Cancer Res. 1990. PMID: 2317805
-
Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. I. Dose-dependence and kinetics of cyclophosphamide effect.Arch Immunol Ther Exp (Warsz). 1985;33(6):825-9. Arch Immunol Ther Exp (Warsz). 1985. PMID: 3833119
-
The effect of cyclophosphamide and other drugs on the incidence of pulmonary metastases in mice.Cancer Res. 1977 Jan;37(1):145-51. Cancer Res. 1977. PMID: 137074
-
Enhancement by cytotoxic agents of artificial pulmonary metastasis.Br J Cancer. 1977 Dec;36(6):653-8. doi: 10.1038/bjc.1977.247. Br J Cancer. 1977. PMID: 74258 Free PMC article.
-
Enhancement by cyclophosphamide of experimental pulmonary metastases formation of Lewis lung carcinoma. II. Reduction of the cyclophosphamide effect by repopulation with cells from lymphoid organs.Arch Immunol Ther Exp (Warsz). 1985;33(6):831-6. Arch Immunol Ther Exp (Warsz). 1985. PMID: 3914253
Cited by
-
Radiation enhancement of metastasis: a review.Clin Exp Metastasis. 1991 Mar-Apr;9(2):77-104. doi: 10.1007/BF01756381. Clin Exp Metastasis. 1991. PMID: 2032423 Review.
-
A growth-constrained environment drives tumor progression invivo.Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7806-11. doi: 10.1073/pnas.131210498. Epub 2001 Jun 26. Proc Natl Acad Sci U S A. 2001. PMID: 11427708 Free PMC article.
-
Clinical and volumetric predictors of local control after robotic stereotactic radiosurgery for cerebral metastases: active systemic disease may affect local control in the brain.Radiol Oncol. 2020 Nov 10;55(1):82-87. doi: 10.2478/raon-2020-0065. Radiol Oncol. 2020. PMID: 33885238 Free PMC article.
-
A randomized trial of neoadjuvant vs concomitant chemotherapy vs radiotherapy alone in the treatment of stage IV head and neck squamous cell carcinoma.Eur Arch Otorhinolaryngol. 1992;249(4):211-5. doi: 10.1007/BF00178472. Eur Arch Otorhinolaryngol. 1992. PMID: 1642879 Clinical Trial.
-
Learning about the Importance of Mutation Prevention from Curable Cancers and Benign Tumors.J Cancer. 2016 Jan 28;7(4):436-45. doi: 10.7150/jca.13832. eCollection 2016. J Cancer. 2016. PMID: 26918057 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous